"The sizable footprint in Charlotte will enable us to expand our manufacturing workshops, increase our laboratory space and give us significant room to grow in existing specialty markets and enter new markets," said J. Christopher York, president of Bluestar Silicones North America. "In addition, this investment will greatly improve our day-to-day operational efficiencies to become even more responsive to market needs."
The company also intends to increase staffing in sales, marketing and technical service. Employment is projected to increase 25 percent in the next two years at the new Charlotte facility. As part of the plan, existing manufacturing workshops will begin to be transitioned into the Charlotte site towards the end of this year.
According to York, new process equipment will be purchased and installed at the new site for more localized manufacturing to support growth in key markets. In addition, bulk storage capability will be available at the new site to improve efficiency and assure raw material feedstock supply.
This investment also includes expanding Bluestar Silicones R&D capabilities in North America at the new site. Bringing R&D personnel together from Ventura and Rock Hill to Charlotte, combined with larger R&D laboratory facilities, new pilot equipment and increased staffing will offer customers improved technical responsiveness and faster product development.
Bluestar Silicones expects the transition for customers will be seamless in terms of supply with noticeable improvements in its manufacturing environment and operational efficiencies.
The company intends to produce its extensive range of silicone technologies at the Charlotte facility, including liquid silicone rubbers (LSRs), high consistency rubbers (HCRs), room-temperature vulcanized silicones (RTVs), fluids, dispersions, release coatings, specialty fluids, resins and antifoam, marketed under its Silbione, Silcolease, Silcolapse, Lyndcoat and Bluesil trade names.
The new site is expected to be fully transitioned by mid-2013.